Nov 11, 2025 • Benzinga
SOMEWHAT-BULLISH
Integra LifeSciences Receives FDA 510 ( k ) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries - Integra Lifesciences ( NASDAQ:IART )
PRINCETON, N.J., Nov. 11, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation ( NASDAQ:IART ) , a leading global medical technology company, is pleased to announce the FDA 510 ( k ) clearance for use of its CUSA® Clarity Ultrasonic Surgical Aspirator System for cardiac surgeries.
Oct 30, 2025 • Zacks Commentary
NEUTRAL
Integra LifeSciences ( IART ) Q3 Earnings Beat Estimates
Integra (IART) delivered earnings and revenue surprises of +25.58% and -3.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 30, 2025 • GlobeNewswire
SOMEWHAT-BULLISH
Integra LifeSciences Reports Third Quarter 2025 Financial Results
PRINCETON, N.J., Oct. 30, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation ( Nasdaq: IART ) , a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2025.
Oct 22, 2025 • Business Insider
SOMEWHAT-BULLISH
BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio
MELVILLE, N.Y., Oct. 22, 2025 ( GLOBE NEWSWIRE ) -- BioRestorative Therapies, Inc. ( "BioRestorative", "BRTX" or the "Company" ) ( NASDAQ: ) , a regenerative medicine innovator focused on stem cell-based therapies and products, today announced that Crystal Romano has joined its management team.
Oct 22, 2025 • GlobeNewswire
NEUTRAL
BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio
MELVILLE, N.Y., Oct. 22, 2025 ( GLOBE NEWSWIRE ) -- BioRestorative Therapies, Inc. ( "BioRestorative", "BRTX" or the "Company" ) ( NASDAQ:BRTX ) , a regenerative medicine innovator focused on stem cell-based therapies and products, today announced that Crystal Romano has joined its management ...
Oct 15, 2025 • Benzinga
SOMEWHAT-BULLISH
Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025 - Integra Lifesciences ( NASDAQ:IART )
PRINCETON, N.J., Oct. 15, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation ( NASDAQ:IART ) , a leading global medical technology company, will release third quarter 2025 financial results on Thursday, October 30, 2025, prior to the market open.